glp 1 level GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes Pharmacological, but not physiological, levels
Description
In type 2 diabetes, the primary therapeutic objective is to reduce blood glucose levels and lower HbA1c
B.NielsenP
Race and ethnicity and pharmacy dispensing of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes
Understanding the mechanisms behind this effect is essential for clinicians and patients alike
The decrease in mean GFR at 52 weeks was smaller in the high (1.5 mg) and low dose dulaglutide (0.75 mg) treatment groups (both 0.7 ml/min/1.73 m2) vs
(2013) Effects of exenatide and liraglutide on heart rate, blood pressure and body weight: systematic review and meta-analysis
